Subscribe To Our Free Newsletter |
Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
Biocon Biologics, a subsidiary of Biocon, has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies (mAbs) drug substance facility at Bengaluru.